Statement Of Cash Flows [Abstract]

Isofol Medical - Filing #701188

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid (refund), classified as operating activities
- SEK
1,000 SEK
Cash flows from (used in) operating activities
188 429 SEK
160 270 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
- SEK
- SEK
Cash flows from (used in) investing activities
- SEK
- SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
451 917 SEK
151 258 SEK
Proceeds from issuing other equity instruments
1 08 SEK
308,000 SEK
Payments of lease liabilities, classified as financing activities
1 548 SEK
1 553 SEK
Cash flows from (used in) financing activities
450 47 7 SEK
150 013 SEK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
262 048 SEK
10 257 SEK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1 007 SEK
3 3 4 SEK
Cash and cash equivalents
379 448 SEK
116 393 SEK
126 983 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.